Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial
Titel:
Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial
Auteur:
Badje, Anani Moh, Raoul Gabillard, Delphine Guéhi, Calixte Kabran, Mathieu Ntakpé, Jean-Baptiste Carrou, Jérôme Le Kouame, Gérard M Ouattara, Eric Messou, Eugène Anzian, Amani Minga, Albert Gnokoro, Joachim Gouesse, Patrice Emieme, Arlette Toni, Thomas-d'Aquin Rabe, Cyprien Sidibé, Baba Nzunetu, Gustave Dohoun, Lambert Yao, Abo Kamagate, Synali Amon, Solange Kouame, Amadou-Barenson Koua, Aboli Kouamé, Emmanuel Daligou, Marcelle Hawerlander, Denise Ackoundzé, Simplice Koule, Serge Séri, Jonas Ani, Alex Dembélé, Fassery Koné, Fatoumata Oyebi, Mykayila Mbakop, Nathalie Makaila, Oyewole Babatunde, Carolle Babatunde, Nathaniel Bleoué, Gisèle Tchoutedjem, Mireille Kouadio, Alain-Claude Sena, Ghislaine Yededji, Sahinou-Yediga Karcher, Sophie Rouzioux, Christine Kouame, Abo Assi, Rodrigue Bakayoko, Alima Domoua, Serge K Deschamps, Nina Aka, Kakou N'Dri-Yoman, Thérèse Salamon, Roger Journot, Valérie Ahibo, Hughes Ouassa, Timothée Menan, Hervé Inwoley, André Danel, Christine Eholié, Serge P Anglaret, Xavier
Verschenen in:
The Lancet global health
Paginering:
Jaargang 5 () nr. 11 pagina's e1080-e1089
Jaar:
2017
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license